Mert Aktar

Insider Reports History

Location
New York, NY
Signature
By: /s/ Ryan Jones, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mert Aktar:

Company Role Class Num Shares Value Price $ Report Date Ownership
Kyverna Therapeutics, Inc. Director Common Stock 16,634 $35,097 $2.11 29 May 2025 Direct
Kyverna Therapeutics, Inc. Director Stock Option (right to buy) 65,351 29 May 2025 Direct

Insider Reports Filed by Mert Aktar

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KYTX Kyverna Therapeutics, Inc. 29 May 2025 2 $0 4 Director 02 Jun 2025, 18:32
KYTX Kyverna Therapeutics, Inc. 21 Oct 2024 1 $0 4 Director 24 Oct 2024, 06:05
KYTX Kyverna Therapeutics, Inc. 21 Oct 2024 0 $0 3 Director 24 Oct 2024, 06:02